Peptide Therapeutics intermediate
Zavegepant - Migraine (NCT03872453)
Phase III trial of zavegepant for acute migraine. This peptide or oligopeptide is studied for its biological activity, structure-activity relationships, and ...
By Encyclopeptide Editorial | 1 min read
zavegepant-migraine-nct03872453 peptide research
Overview
Phase III trial of zavegepant for acute migraine.
Clinical Significance
This topic has important implications for peptide research and clinical applications.
References
- Encyclopeptide Database. “Zavegepant - Migraine (NCT03872453)” monograph. encyclopeptide.com.
Test Your Knowledge
Reinforce what you learned about Zavegepant - Migraine (NCT03872453) with interactive quizzes on Wikipept.
Take a Quiz on Wikipept